Atrial fibrillation (AF) is the most common cardiac arrhythmia, its prevalence increasing
markedly with age. Atrial fibrillation is strongly associated with increased risk of morbidity …

The PhysioNet/Computing in Cardiology (CinC) Challenge 2017 focused on differentiating
AF from noise, normal or other rhythms in short term (from 9-61 s) ECG recordings …

Heart failure affects nearly 6 million Americans, with a half-million new cases emerging each
year. Whereas up to 50% of heart failure patients die of arrhythmia, the diverse mechanisms …

Estimates and projections of diagnosed incidence and prevalence of atrial fibrillation (AF) in
the United States have been highly inconsistent across published studies. Although it is …

Objective: We aim to combine deep neural networks and engineered features (hand-crafted
features based on medical domain knowledge) for cardiac arrhythmia detection from short …

BACKGROUND: Obesity is associated with the development of atrial fibrillation and may
impact atrial fibrillation-related outcomes. To date, no anthropometric measure is included in …

Atrial fibrosis with enhanced turnover and deposition of matrix proteins leads to
inhomogeneous atrial electrical conduction and gives rise to electrical reentry circuits …

Edoxaban is an oral direct factor Xa inhibitor that is currently undergoing investigation in
phase III clinical trials for the prevention of stroke in patients with atrial fibrillation (AF) and for …

Background The prevalence of atrial fibrillation is increasing rapidly; however, to date,
population-based data are lacking on the attributable cost of illness of atrial fibrillation from a …

Aims Atrial fibrillation (AF) is not always perceived as a serious health threat, but is the most
common sustained arrhythmia, with a major impact on morbidity, mortality, and patient …